Evidence map›Paper›PMID 23874419›Full record

SynthesisPloS one2013

Development and validation of a risk score predicting substantial weight gain over 5 years in middle-aged European men and women.

Annika Steffen, Thorkild I A Sørensen, Sven Knüppel, Noemie Travier, María-José Sánchez, José María Huerta, J Ramón Quirós, Eva Ardanaz, Miren Dorronsoro, Birgit Teucher and 25 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. The future burden of obesity in Canada: a modelling study.Canadian journal of public health = Revue canadienne de sante publique · 2019
    Article
  4. Article
  5. Article
  6. Article
  7. Erythritol is a pentose-phosphate pathway metabolite and associated with adiposity gain in young adults.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 20 institutions in 10 countries.

Annika SteffenDepartment of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany. annika.steffen@dife.de
Thorkild I A Sørensen
Sven Knüppel
Noemie Travier
María-José Sánchez
José María Huerta
J Ramón Quirós
Eva Ardanaz
Miren Dorronsoro
Birgit Teucher
Kuanrong Li
H Bas Bueno-de-Mesquita
Daphne van der A
Amalia Mattiello
Domenico Palli
Rosario Tumino
Vittorio Krogh
Paolo Vineis
Antonia Trichopoulou
Philippos Orfanos
Dimitrios Trichopoulos
Bo Hedblad
Peter Wallström
Kim Overvad
Jytte Halkjær
Anne Tjønneland
Guy Fagherazzi
Laureen Dartois
Francesca Crowe
Kay-Tee Khaw
Nick Wareham
Lefkos Middleton
Anne M May
Petra H M Peeters
Heiner Boeing
Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESGerman Institute of Human Nutrition · DEUniversity Medical Center Utrecht · NLDanish Cancer Society · DKNational and Kapodistrian University of Athens · GRUniversity of Cambridge · GBAarhus University · DKAzienda Usl 8 Arezzo · ITBiogipuzkoa Health Research Institute · ESCopenhagen University Hospital · DKFondazione IRCCS Istituto Nazionale dei Tumori · ITGerman Cancer Research Center · DEGobierno del Principado de Asturias · ESHeidelberg University · DEHellenic Health Foundation · GRImperial College London · GBInserm · FRInstitut Català d'Oncologia · ESInstitut Gustave Roussy · FRItalian institute for Genomic Medicine · IT

Funding

British Heart FoundationCancer Research UK 14136Department of HealthMedical Research Council G0401527Medical Research Council G1000143Wellcome Trust
6 · The paper itself

Abstract

backgroundIdentifying individuals at high risk of excess weight gain may help targeting prevention efforts at those at risk of various metabolic diseases associated with weight gain. Our aim was to develop a risk score to identify these individuals and validate it in an external population.

methodsWe used lifestyle and nutritional data from 53°758 individuals followed for a median of 5.4 years from six centers of the European Prospective Investigation into Cancer and Nutrition (EPIC) to develop a risk score to predict substantial weight gain (SWG) for the next 5 years (derivation sample). Assuming linear weight gain, SWG was defined as gaining ≥ 10% of baseline weight during follow-up. Proportional hazards models were used to identify significant predictors of SWG separately by EPIC center. Regression coefficients of predictors were pooled using random-effects meta-analysis. Pooled coefficients were used to assign weights to each predictor. The risk score was calculated as a linear combination of the predictors. External validity of the score was evaluated in nine other centers of the EPIC study (validation sample).

resultsOur final model included age, sex, baseline weight, level of education, baseline smoking, sports activity, alcohol use, and intake of six food groups. The model's discriminatory ability measured by the area under a receiver operating characteristic curve was 0.64 (95% CI = 0.63-0.65) in the derivation sample and 0.57 (95% CI = 0.56-0.58) in the validation sample, with variation between centers. Positive and negative predictive values for the optimal cut-off value of ≥ 200 points were 9% and 96%, respectively.

conclusionThe present risk score confidently excluded a large proportion of individuals from being at any appreciable risk to develop SWG within the next 5 years. Future studies, however, may attempt to further refine the positive prediction of the score.

Indexed as

AdultAgedEuropeFemaleHumansMaleMiddle AgedProportional Hazards ModelsProspective StudiesRisk FactorsWeight Gain

Identifiers

PMID23874419
PMCPMC3713004
OpenAlexW2166913034

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.